These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia. Memis A; Ozden C; Ozdal OL; Guzel O; Han O; Seckin S Urol Int; 2008; 80(2):177-80. PubMed ID: 18362489 [TBL] [Abstract][Full Text] [Related]
11. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. McConnell JD; Bruskewitz R; Walsh P; Andriole G; Lieber M; Holtgrewe HL; Albertsen P; Roehrborn CG; Nickel JC; Wang DZ; Taylor AM; Waldstreicher J N Engl J Med; 1998 Feb; 338(9):557-63. PubMed ID: 9475762 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater. Kaplan SA; McConnell JD; Roehrborn CG; Meehan AG; Lee MW; Noble WR; Kusek JW; Nyberg LM; J Urol; 2006 Jan; 175(1):217-20; discussion 220-1. PubMed ID: 16406915 [TBL] [Abstract][Full Text] [Related]
13. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI. Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594 [TBL] [Abstract][Full Text] [Related]
14. [Finanseride in symtomatic benign prostatic hyeprtrophy. A 2-year placebo-controlled study]. Andersen JT; Wolf H; Ekman P; Beisland HO; Johansson JE; Kontturi M; Lehtonen T; Tveter K Ugeskr Laeger; 1996 Sep; 158(36):5030-5. PubMed ID: 8928243 [TBL] [Abstract][Full Text] [Related]
15. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study. Mendichovszky IA; Cutajar M; Gordon I Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588 [TBL] [Abstract][Full Text] [Related]
16. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping. Braren R; Curcic J; Remmele S; Altomonte J; Ebert O; Rummeny EJ; Steingoetter A Invest Radiol; 2011 Oct; 46(10):624-31. PubMed ID: 21577121 [TBL] [Abstract][Full Text] [Related]
17. Effect of finasteride (Proscar MSD) on seminal composition, prostate function and fertility in male dogs. Iguer-Ouada M; Verstegen JP J Reprod Fertil Suppl; 1997; 51():139-49. PubMed ID: 9404280 [TBL] [Abstract][Full Text] [Related]
18. A method for pharmacokinetic modelling of dynamic contrast enhanced MRI studies of rapidly enhancing lesions acquired in a clinical setting. Radjenovic A; Ridgway JP; Smith MA Phys Med Biol; 2006 May; 51(9):N187-97. PubMed ID: 16625029 [TBL] [Abstract][Full Text] [Related]